« Critics say program offering money for contraception to HIV-positive Kenyan | Main | FDA Approvals - FDA biopharmaceutical drug approvals increase despite slower development timeThe U.S. »

FDA requests input on development of user fee program for


FDA requests input on development of user fee program for biosimilar and interchangeable biological products
The U.S. Food and Drug Administration is requesting input from stakeholders and the public relating to the development of a user fee program for biosimilar and interchangeable biological product (351(k)) applications.
 

©2006 FDA-News.com. All rights reserved.